Prostacyclin-mediated compensatory mechanism in the coronary circulation during acute NO synthase blockade

Life Sciences

Volumn 73, Issue 9, 2003, Pages 1141-1149

  Lacza, Zsombor ^a   Dézsi, László ^b   Káldi, Krisztina ^a   Horváth, Eszter M ^a   Sándor, Péter ^a   Benyó, Zoltán ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b GEDEON RICHTER LTD   (Hungary)

Author keywords

Coronary circulation; Endothelium; Nitric oxide; Prostacyclin

Indexed keywords

ARGININE; INDOMETACIN; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE; PROSTACYCLIN;

ANIMAL TISSUE; ARTERY TONE; ARTICLE; CORONARY ARTERY BLOOD FLOW; DYNAMICS; ENZYME INHIBITION; FLOW MEASUREMENT; HEART FUNCTION; HEART PERFUSION; HEART RATE; ISOLATED ORGAN; LIPOGENESIS; NONHUMAN; RAT;

EID: 0038343598     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00427-2     Document Type: Article

References (49)

1. Albertini M., Vanelli G., Clement M.G. PGI2 and nitric oxide involvement in the regulation of systemic and pulmonary basal vascular tone in the pig. Prostaglandins Leukot Essent Fatty Acids. 54:1996;273-278.
2. Altman J.D., Kinn J., Duncker D.J., Bache R.J. Effect of inhibition of nitric oxide formation on coronary blood flow during exercise in the dog. Cardiovasc Res. 28:1994;119-124.
3. Barker J.E., Bakhle Y.S., Anderson J., Treasure T., Piper P.J. Reciprocal inhibition of nitric oxide and prostacyclin synthesis in human saphenous vein. Br J Pharmacol. 118:1996;643-648.
4. Bauersachs J., Popp R., Hecker M., Sauer E., Fleming I., Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation. 94:1996;3341-3347.
5. Benyo Z., Kiss G., Szabo C., Csaki C., Kovach A.G. Importance of basal nitric oxide synthesis in regulation of myocardial blood flow. Cardiovasc Res. 25:1991;700-703.
6. Berti F., Rossoni G., Della B.D., Villa L.M., Buschi A., Trento F., Berti M., Tondo C. Nitric oxide and prostacyclin influence coronary vasomotor tone in perfused rabbit heart and modulate endothelin-1 activity. J Cardiovasc Pharmacol. 22:1993;321-326.
7. Beverelli F., Bea M.L., Puybasset L., Giudicelli J.F., Berdeaux A. Chronic inhibition of NO synthase enhances the production of prostacyclin in coronary arteries through upregulation of the cyclooxygenase type 1 isoform. Fundam Clin Pharmacol. 11:1997;252-259.
8. Boczkowski J., Vicaut E., Danialou G., Aubier M. Role of nitric oxide and prostaglandins in the regulation of diaphragmatic arteriolar tone in the rat. J Appl Physiol. 77:1994;590-596.
9. Chataigneau T., Feletou M., Huang P.L., Fishman M.C., Duhault J., Vanhoutte P.M. Acetylcholine-induced relaxation in blood vessels from endothelial nitric oxide synthase knockout mice. Br J Pharmacol. 126:1999;219-226.
10. Coker S.J., Parratt J.R., Ledingham I.M., Zeitlin I.J. Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias. Nature. 291:1981;323-324.
11. Corriu C., Feletou M., Puybasset L., Bea M.L., Berdeaux A., Vanhoutte P.M. Endothelium-dependent hyperpolarization in isolated arteries taken from animals treated with NO-synthase inhibitors. J Cardiovasc Pharmacol. 32:1998;944-950.
12. Danielson L.A., Conrad K.P. Prostaglandins maintain renal vasodilation and hyperfiltration during chronic nitric oxide synthase blockade in conscious pregnant rats. Circ Res. 79:1996;1161-1166.
13. Doni M.G., Whittle B.J., Palmer R.M., Moncada S. Actions of nitric oxide on the release of prostacyclin from bovine endothelial cells in culture. Eur J Pharmacol. 151:1988;19-25.
14. Edlund A., Fredholm B.B., Patrignani P., Patrono C., Wennmalm A., Wennmalm M. Release of two vasodilators, adenosine and prostacyclin, from isolated rabbit hearts during controlled hypoxia. J Physiol. 340:1983;487-501.
15. Egashira K., Katsuda Y., Mohri M., Kuga T., Tagawa T., Kubota T., Hirakawa Y., Takeshita A. Role of endothelium-derived nitric oxide in coronary vasodilatation induced by pacing tachycardia in humans. Circ Res. 79:1996;331-335.
16. Feliciano L., Henning R.J. Coronary artery blood flow: physiologic and pathophysiologic regulation. Clin Cardiol. 22:1999;775-786.
17. Frangos J.A., Eskin S.G., McIntire L.V., Ives C.L. Flow effects on prostacyclin production by cultured human endothelial cells. Science. 227:1985;1477-1479.
18. Godecke A., Decking U.K., Ding Z., Hirchenhain J., Bidmon H.J., Godecke S., Schrader J. Coronary hemodynamics in endothelial NO synthase knockout mice. Circ Res. 82:1998;186-194.
19. Gupte S.A., Okada T., Ochi R. Superoxide and nitroglycerin stimulate release of PGF2 alpha and TxA2 in isolated rat heart. Am J Physiol. 271:1996;H2447-H2453.
20. Heras M., Roig E., Perez-Villa F., Paz M., Melis G., Rigol M., Epelde F., de Candia G., Sanz G. The role of endogenous nitric oxide in the response of coronary blood flow to tachycardia. Coron Artery Dis. 7:1996;149-154.
21. Huang M., Manning R.D.J., LeBlanc M.H., Hester R.L. Overall hemodynamic studies after the chronic inhibition of endothelial-derived nitric oxide in rats. Am J Hypertens. 8:1995;358-364.
22. Huang A., Wu Y., Sun D., Koller A., Kaley G. Effect of estrogen on flow-induced dilation in NO deficiency: role of prostaglandins and EDHF. J Appl Physiol. 91:2001;2561-2566.
23. Ivanics T., Osbakken M.D., Dezsi L., Doliba N., Megyeri K. Effects of vasoactive agents on myocardial bioenergetics. J Appl Cardiol. 6:1991;211-220.
24. Jones C.J., Kuo L., Davis M.J., DeFily D.V., Chilian W.M. Role of nitric oxide in the coronary microvascular responses to adenosine and increased metabolic demand. Circulation. 91:1995;1807-1813.
25. Kanner J., Harel S., Granit R. Nitric oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin. Lipids. 27:1992;46-49.
26. Katsuda Y., Egashira K., Akatsuka Y., Narishige T., Shimokawa H., Takeshita A. Endothelium-derived nitric oxide does not modulate metabolic coronary vasodilation induced by tachycardia in dogs. J Cardiovasc Pharmacol. 26:1995;437-444.
27. Kosonen O., Kankaanranta H., Malo-Ranta U., Ristimaki A., Moilanen E. Inhibition by nitric oxide-releasing compounds of prostacyclin production in human endothelial cells. Br J Pharmacol. 125:1998;247-254.
28. Kostic M.M., Schrader J. Role of nitric oxide in reactive hyperemia of the guinea pig heart. Circ Res. 70:1992;208-212.
29. Lamontagne D., Konig A., Bassenge E., Busse R. Prostacyclin and nitric oxide contribute to the vasodilator action of acetylcholine and bradykinin in the intact rabbit coronary bed. J Cardiovasc Pharmacol. 20:1992;652-657.
30. Maekawa K., Saito D., Obayashi N., Uchida S., Haraoka S. Role of endothelium-derived nitric oxide and adenosine in functional myocardial hyperemia. Am J Physiol. 267:1994;H166-H173.
31. Matsunaga T., Okumura K., Tsunoda R., Tayama S., Tabuchi T., Yasue H. Role of adenosine in regulation of coronary flow in dogs with inhibited synthesis of endothelium-derived nitric oxide. Am J Physiol. 270:1996;H427-H434.
32. Matthews J.S., McWilliams P.J., Key B.J., Keen M. Inhibition of prostacyclin release from cultured endothelial cells by nitrovasodilator drugs. Biochim Biophys Acta. 1269:1995;237-242.
33. McCulloch A.I., Bottrill F.E., Randall M.D., Hiley C.R. Characterization and modulation of EDHF-mediated relaxations in the rat isolated superior mesenteric arterial bed. Br J Pharmacol. 120:1997;1431-1438.
34. Merkus D., Chilian W.M., Stepp D.W. Functional characteristics of the coronary microcirculation. Herz. 24:1999;496-508.
35. Minamino T., Kitakaze M., Node K., Funaya H., Hori M. Inhibition of nitric oxide synthesis increases adenosine production via an extracellular pathway through activation of protein kinase C. Circulation. 96:1997;1586-1592.
36. Nishikawa Y., Ogawa S. Importance of nitric oxide in the coronary artery at rest and during pacing in humans. J Am Coll Cardiol. 29:1997;85-92.
37. Okada T. Hypoxia-induced change in prostanoids production and coronary flow in isolated rat heart. J Mol Cell Cardiol. 23:1991;939-948.
38. Pomposiello S., Yang X.P., Liu Y.H., Surakanti M., Rhaleb N.E., Sevilla M., Carretero O.A. Autacoids mediate coronary vasoconstriction induced by nitric oxide synthesis inhibition. J Cardiovasc Pharmacol. 30:1997;599-606.
39. Puybasset L., Bea M.L., Ghaleh B., Giudicelli J.F., Berdeaux A. Coronary and systemic hemodynamic effects of sustained inhibition of nitric oxide synthesis in conscious dogs. Evidence for cross talk between nitric oxide and cyclooxygenase in coronary vessels. Circ Res. 79:1996;343-357.
40. Quyyumi A.A., Dakak N., Andrews N.P., Gilligan D.M., Panza J.A., Cannon R.O.r. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation. 92:1995;320-326.
41. Rubanyi G.M., Romero J.C., Vanhoutte P.M. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol. 250:1986;H1145-H1149.
42. Shah A.M., MacCarthy P.A. Paracrine and autocrine effects of nitric oxide on myocardial function. Pharmacol Ther. 86:2000;49-86.
43. Sun D., Huang A., Smith C.J., Stackpole C.J., Connetta J.A., Shesely E.G., Koller A., Kaley G. Enhanced release of prostaglandins contributes to flow-induced arteriolar dilation in eNOS knockout mice. Circ Res. 85:1999;288-293.
44. Tayama S., Okumura K., Matsunaga T., Tsunoda R., Tabuchi T., Iwasa A., Yasue H. Influence of chronic nitric oxide inhibition of coronary blood flow regulation: a study of the role of endogenous adenosine in anesthetized, open-chested dogs. Jpn Circ J. 62:1998;371-378.
45. Thelen K.I., Dembinska-Kiec A., Pallapies D., Simmet T., Peskar B.A. Effect of 3-morpholinosydnonimine (SIN-1) and NG-nitro-L-arginine (NNA) on isolated perfused anaphylactic guinea-pig hearts. Naunyn Schmiedebergs Arch Pharmacol. 345:1992;93-99.
46. Thorin E., Huang P.L., Fishman M.C., Bevan J.A. Nitric oxide inhibits alpha2-adrenoceptor-mediated endothelium-dependent vasodilation. Circ Res. 82:1998;1323-1329.
47. Trochu J.N., Bouhour J.B., Kaley G., Hintze T.H. Role of endothelium-derived nitric oxide in the regulation of cardiac oxygen metabolism: implications in health and disease. Circ Res. 87:2000;1108-1117.
48. Woolfson R.G., Patel V.C., Neild G.H., Yellon D.M. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation. 91:1995;1545-1551.
49. Wu Z., Cao H., Zhou J., Chen Z., Kuang Y. Overproduction of prostacyclin in portal hypertensive rats: relationship to NO production. Gasrtoenterology. 116:1999;L0487. (abstract).